Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof | Patent Publication Number 20120071403

US 20120071403 A1
Patent NumberUS 08685934 B2
Application Number13321103
Filled DateMay 26, 2010
Priority DateMay 27, 2009
Publication DateMar 22, 2012
Original AssigneeAstrazeneca
Bristol Myers Squibb
Current AssigneeAstrazeneca
Inventor/ApplicantsPaul Strumph
Stephanie Moran
James List
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.